Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07494136 · ClinicalTrials.gov registry record · Phase 4
Dose Dependent Steroid Injections
A Phase 4 study, sponsored by University of Miami.
- Not yet
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT07494136 is a Phase 4 study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 150 participants.
The verdict
NCT07494136, a Phase 4 study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
This study aims to evaluate the efficacy of interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, to evaluate the efficacy of interlaminar steroid injections at improving quality of life and function in lumbar radiculopathy at varying doses, and to evaluate difference in efficacy between triamcinolone and dexamethasone interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, with the overarching hypotheses that there is no difference in reported pain reduction, quality of life, or function among patients receiving low, moderate, or high doses, and no difference in reported pain reduction between triamcinolone and dexamethasone.
Interventions
- DRUG Dexamethasone 4mg
- DRUG Triamcinolone 10 Mg/mL Injectable Suspension
- DRUG Triamcinolone 40 Mg/mL Injectable Suspension
- DRUG Triamcinolone 80 Mg/mL Injectable Suspension
- DRUG Dexamethasone 2 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07494136
The ClinicalTrials.gov registry entry for NCT07494136 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Dexamethasone 4mg is the first listed.
NCT07494136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07494136 about?
NCT07494136 is a clinical study titled "Dose Dependent Steroid Injections". This study aims to evaluate the efficacy of interlaminar steroid injections at treating pain in lumbar radiculopathy at varying doses, to evaluate the efficacy of interlaminar steroid injections at improving quality of life and function in lumbar radiculopathy at varying doses, and to evaluate diffe...
What is the current status of trial NCT07494136?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2026-05. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07494136?
The interventions under investigation include: Dexamethasone 4mg (DRUG), Triamcinolone 10 Mg/mL Injectable Suspension (DRUG), Triamcinolone 40 Mg/mL Injectable Suspension (DRUG), Triamcinolone 80 Mg/mL Injectable Suspension (DRUG), Dexamethasone 2 MG (DRUG).
Who is sponsoring clinical trial NCT07494136?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.